Physician profile
Dean R Marson
NPI 1497854285
$1,624.33
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $67.84 · 2021: $11.46.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,295.31 | 2019 | |
| Davol INC. | $108.03 | 2019 | |
| Angiodynamics, INC. | $97.69 | 2019 | |
| Merck Sharp & Dohme LLC | $32.21 | 2020 | |
| Tactile Systems Technology INC | $31.17 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $25.48 | 2020-2021 | |
| Kci USA, INC. | $21.61 | 2020 | |
| Getinge USA Sales, LLC | $12.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Marson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.